|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/55 | |
| A61K 39/395 | |||
| A61K 35/16 | |||
| A61P 25/28 |
| (11) | Patento numeris | 3068424 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14802790.7 |
| Europos patento paraiškos padavimo data | 2014-11-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/065180 |
| Data | 2014-11-12 |
| (87) | Numeris | WO 2015/073514 |
| Data | 2015-05-21 |
| (30) | Numeris | Data | Šalis |
| 201361903643 P | 2013-11-13 | US |
| (72) |
BROOM, Colin, US
DAYNO, Jeffrey, US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDERS |
| COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDERS |